Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 24:53:101139.
doi: 10.1016/j.nmni.2023.101139. eCollection 2023 Jun.

Spotted fever group rickettsiae and Anaplasma phagocytophilum in Borrelia burgdorferi sensu lato seropositive individuals with or without Lyme disease: A retrospective analysis

Affiliations

Spotted fever group rickettsiae and Anaplasma phagocytophilum in Borrelia burgdorferi sensu lato seropositive individuals with or without Lyme disease: A retrospective analysis

Leonie Kosak et al. New Microbes New Infect. .

Abstract

Background: The Ixodes ricinus tick is the main vector of Borrelia burgdorferi and tick-borne encephalitis virus in Switzerland. Spotted fever group Rickettsiae (SFG) and Anaplasma phagocytophilum have been detected in Swiss ticks, however, information about the extent and clinical presentation of these infections in humans is scant.

Methods: Indirect fluorescent antibody tests for SFG rickettsiae and Anaplasma phagocytophilum were performed on serum samples of 121 Borrelia burgdorferi seropositive patients with and without Lyme disease and 43 negative controls.

Results: Out of 121 Borrelia burgdorferi seropositive individuals, 65 (53.7%) were seropositive for IgG and 15 (12.4%) for IgM antibodies to SFG rickettsiae. IgM antibodies were detected more frequently in early-than in late-stage of Lyme disease (12 out of 51 and 2 out of 49; respectively; p ​= ​0.0078). Significantly higher IgG antibody titers against SFG rickettsiae were found in patients with late-stage compared to patients with early-stage Lyme disease (mean titer 1:261 and 1:129, respectively; p ​= ​0.038). This difference was even more pronounced in patients with acrodermatitis chronica atrophicans compared to patients with early stage of Lyme disease (mean titer 1:337 and 1:129, respectively; p ​= ​0.009).In patients presenting with fatigue, headache and myalgia, the prevalence of IgG antibodies against SFG rickettsiae was significantly higher (7 out of 11; 63.6%) than in Borrelia burgdorferi seropositive individuals without clinical illness (1 out of 10; 10%; p ​= ​0.024). IgG antibodies to Anaplasma phagocytophilum were detected in 12 out of 121 individuals (9.9%), no IgM antibodies were found.

Conclusion: Infections with SFG rickettsiae and Anaplasma phagocytophilum are underdiagnosed and should be ruled out after a tick bite. Further studies are needed to elucidate the possible causative role of SFG rickettsiae for myalgia, headache and long-lasting fatigue after a tick bite and to determine the necessity for an antibiotic treatment.

Keywords: Acrodermatitis atrophicans chronica; Anaplasma phagocytophilum; Borrelia; Co-infection; Lyme disease; SFG rickettsiae; Switzerland; Tick bite.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Seroprevalence of spotted fever group (SFG) rickettsiae in Borrelia burgdorferi seropositive patients with and without Lyme disease compared to control group.
Fig. 2
Fig. 2
Seroprevalence of IgM antibodies against spotted fever group (SFG) rickettsiae in Borrelia burgdorferi seropositive patients with Lyme disease.
Fig. 3
Fig. 3
IgG antibodies against spotted fever group (SFG) rickettsiae in B.burgdorferi seropositive patients with Lyme disease and in individuals seropositive for B. burgdorferi, but without clinical signs typical for Lyme disease.
Fig. 4
Fig. 4
IgG antibodies against spotted fever group (SFG) rickettsiae in B. burgdorferi seropositive patients presenting with myalgia, headache and fatigue in comparison to B. burgdorferi seropositive individuals without clinical illness.

References

    1. Walker A.R., Bowman A., Nuttall P. Ticks: biology, disease and control. Parasites Vectors. 2009;2(1) doi: 10.1186/1756-3305-2-1. - DOI
    1. Lommano E., Dvorak C., Vallotton L., Jenni L., Gern L. Tick-borne pathogens in ticks collected from breeding and migratory birds in Switzerland. Ticks Tick Borne Dis. 2014;5(6):871–882. doi: 10.1016/j.ttbdis.2014.07.001. - DOI - PubMed
    1. Sprong H., Azagi T., Hoornstra D., et al. Control of Lyme borreliosis and other Ixodes ricinus-borne diseases. Parasites Vectors. 2018;11 doi: 10.1186/s13071-018-2744-5. 145. - DOI - PMC - PubMed
    1. Olafsdottir B., Askling H.H. Increasing spread of borreliosis in Europe. New Microbes New Infect. 2022 Aug 29;48 doi: 10.1016/j.nmni.2022.101022. - DOI - PMC - PubMed
    1. Hofhuis A., Harms M., van den Wijngaard C., Sprong H., van Pelt W. Continuing increase of tick bites and Lyme disease between 1994 and 2009. Ticks Tick Borne Dis. 2015 Feb;6(1):69–74. doi: 10.1016/j.ttbdis.2014.09.006. - DOI - PubMed

LinkOut - more resources